Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks: A Prospective Cohort Study in Mexico City

NCT02745093 is registered in ClinicalTrials.gov with Ibis Reproductive Health as lead sponsor.

NCT NCT02745093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02745093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks: A Prospective Cohort Study in Mexico City
Lead sponsor
Ibis Reproductive Health
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2016
Enrollment
648 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

medical abortion